Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,600

Sort by:

Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalomyelitis (Central Nervous S...

June 2021 69 pages

Epilepsy (Central Nervous System) - Drugs In Development, 2021

US$ 2,500.00

Epilepsy (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy (Central Nervous System) - Drugs In...

June 2021 789 pages

Exportin 1 - Drugs In Development, 2021

US$ 3,500.00

Exportin 1 - Drugs In Development, 2021 SUMMARY Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 mo...

June 2021 143 pages

Familial Adenomatous Polyposis (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Familial Adenomatous Polyposis (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous P...

June 2021 87 pages

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021

US$ 3,500.00

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021 SUMMARY Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a p...

June 2021 77 pages

Gonorrhea (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Gonorrhea (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea (Infectious Disease) - Drugs In Develo...

June 2021 127 pages

Gorlin Syndrome (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Gorlin Syndrome (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Oncology) - Drugs In Development, 2...

June 2021 186 pages

Granulomatosis with Polyangiitis (Immunology) - Drugs In Development, 2021

US$ 2,000.00

Granulomatosis with Polyangiitis (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis...

June 2021 147 pages

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Drugs In Development, 2021

US$ 3,500.00

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Drugs In Development, 2021 SUMMARY Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an impo...

June 2021 61 pages

Iduronate 2 Sulfatase - Drugs In Development, 2021

US$ 3,500.00

Iduronate 2 Sulfatase - Drugs In Development, 2021 SUMMARY According to the recently published report 'Iduronate 2 Sulfatase - Drugs In Development, 2021'; Iduronate 2 Sulfatase (Alpha L Iduronate Sul...

June 2021 75 pages

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Drugs In Development, 2021

US$ 3,500.00

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Drugs In Development, 2021 SUMMARY Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) pipeline Target cons...

June 2021 74 pages

Leukotriene A 4 Hydrolase - Drugs In Development, 2021

US$ 3,500.00

Leukotriene A 4 Hydrolase - Drugs In Development, 2021 SUMMARY Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) pipeline Target constitutes close to 6 mol...

June 2021 50 pages

Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021

US$ 2,000.00

Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis (Gastrointestinal) - Drugs I...

June 2021 178 pages

Meniere Disease (Ear Nose Throat Disorders) - Drugs In Development, 2021

US$ 2,000.00

Meniere Disease (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere Disease (Ear Nose Throat Di...

June 2021 43 pages

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Drugs In Development, 2021

US$ 3,500.00

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Drugs In Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M2 (CHRM2) pipeline Target constitutes close to 10 molecules. The latest report Musc...

June 2021 86 pages

Muscarinic Acetylcholine Receptor M4 (CHRM4) - Drugs In Development, 2021

US$ 3,500.00

Muscarinic Acetylcholine Receptor M4 (CHRM4) - Drugs In Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M4 (CHRM4) - Muscarinic acetylcholine receptor M4 or cholinergic receptor muscarinic...

June 2021 96 pages

Myocardial Ischemia (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Myocardial Ischemia (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia (Cardiovascular) - Dru...

June 2021 96 pages

Myocarditis (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Myocarditis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Developmen...

June 2021 57 pages

N Sulphoglucosamine Sulphohydrolase - Drugs In Development, 2021

US$ 3,500.00

N Sulphoglucosamine Sulphohydrolase - Drugs In Development, 2021 SUMMARY According to the recently published report 'N Sulphoglucosamine Sulphohydrolase - Drugs In Development, 2021'; N Sulphoglucosam...

June 2021 60 pages

Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021

US$ 2,000.00

Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal...

June 2021 95 pages

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Drugs In Development, 2021

US$ 3,500.00

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Drugs In Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Neuronal acetylcholine receptor subunit beta-2 is...

June 2021 63 pages

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021

US$ 3,500.00

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Neuropeptide Y Receptor Type 2 - Drugs In Development, 2021';...

June 2021 37 pages

Osteogenesis Imperfecta (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Osteogenesis Imperfecta (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteogenesis Imperfecta (Geni...

June 2021 90 pages

Osteomyelitis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Osteomyelitis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis (Infectious Disease) - Drugs I...

June 2021 55 pages

Pressure Ulcers (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Pressure Ulcers (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers (Dermatology) - Drugs In Developm...

June 2021 30 pages

Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Defici...

June 2021 143 pages

Proto Oncogene Tyrosine Protein Kinase Src - Drugs In Development, 2021

US$ 3,500.00

Proto Oncogene Tyrosine Protein Kinase Src - Drugs In Development, 2021 SUMMARY Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) pipeline Target con...

June 2021 109 pages

Pruritus (Dermatology) - Drugs In Development, 2021

US$ 2,000.00

Pruritus (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus (Dermatology) - Drugs In Development, 2021, pro...

June 2021 221 pages

Pulmonary Embolism (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Pulmonary Embolism (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism (Cardiovascular) - Drugs...

June 2021 44 pages

Restenosis (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Restenosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis (Cardiovascular) - Drugs In Development,...

June 2021 40 pages

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sandhoff...

June 2021 53 pages

Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021

US$ 3,500.00

Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021 SUMMARY Somatostatin Receptor Type 4 (SSTR4) pipeline Target constitutes close to 5 molecules. The latest report Somatostatin Receptor...

June 2021 41 pages

Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy...

June 2021 186 pages

Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neura...

June 2021 80 pages

Tyrosine Protein Kinase Mer - Drugs In Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase Mer - Drugs In Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase Mer - Drugs In Development, 2021'; Tyrosine Protein Kinase Mer (Pro...

June 2021 94 pages

Vaccine Delivery Devices: Global Markets

US$ 5,500.00

Report This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery...

June 2021 141 pages

What’s Ahead for the Animal Health Industry?-Emerging Opportunities and Growth Strategies for Suppliers

US$ 2,750.00

Will the industry consolidate, decentralize, or undergo a bimodal transformation?How will the current trends affect the major market segments?Which companies will enter the market and which will not s...

June 2021 110 pages

Investigation Report on China's Recombinant human thrombopoietin (rhTPO) Market 2021-2025

US$ 2,600.00

... with thrombopenia increases in China, the demand for Recombinant Human Thrombopoietin will also increase. Considering the high growth rate of the Recombinant Human Thrombopoietin market, Recombinant Human Thrombopoietin products by other ...

June 2021 50 pages

Investigation Report on China's Acetylcysteine Market 2021-2025

US$ 2,600.00

Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with chronic bronchopulmonary...

June 2021 50 pages

Investigation Report on China's Anlotinib Market 2021-2025

US$ 2,600.00

Anlotinib is an oral multi-targeting small-molecule tyrosine kinase inhibitor that can target multiple angiogenic factor receptors to inhibit tumor angiogenesis. It can be used for advanced non-small...

June 2021 50 pages

Investigation Report on China's Dexmedetomidine Market 2021-2025

US$ 2,600.00

Dexmedetomidine is a highly selective ?2-adrenergic receptor agonist. It is mainly used clinically for the sedation of tracheal intubation and mechanical ventilation in surgical patients undergoing ge...

June 2021 50 pages

Investigation Report on China's Doxorubicin Market 2021-2025

US$ 2,600.00

Doxorubicin belongs to the anthracycline class (Anthracycline) antibiotics, which can inhibit the synthesis of RNA and DNA. It has a strong inhibitory effect on RNA and has a broad anti-tumor spectrum...

June 2021 50 pages

Investigation Report on China's Emtricitabine/Tenofovir Market 2021-2025

US$ 2,600.00

Emtricitabine/Tenofovir is the first HIV drug approved for prophylaxis. It was developed by Gilead Sciences Inc (the original drug is called TRUVADA). Its product was first approved in the United Stat...

June 2021 50 pages

Investigation Report on China's Enteral Nutrition Market 2021-2025

US$ 2,600.00

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness and malnutrition. It was d...

June 2021 50 pages

Investigation Report on China's Express Delivery Industry 2021-2025

US$ 2,600.00

Express delivery is a door-to-door logistics activity with postal functions, which means express companies use rail, road, and air transportation to quickly deliver customers' goods. According to CRI’...

June 2021 50 pages

Investigation Report on China's Goserelin Market 2021-2025

US$ 2,600.00

Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...

June 2021 50 pages

Investigation Report on China's Hydrotalcite Market, 2021-2025

US$ 2,600.00

Hydrotalcite is suitable for acute and chronic gastritis, reflux esophagitis, gastric and duodenal ulcers, stomach pain, heartburn, acid belching, fullness and other uncomfortable symptoms related to...

June 2021 50 pages

Investigation Report on China's Insulin Glargine Market 2021-2025

US$ 2,600.00

Insulin Glargine is a long-acting human insulin analog that can control the patient's blood sugar more effectively and steadily. It is often used to treat type 1 and type 2 diabetes. Its original rese...

June 2021 50 pages

Investigation Report on China's Leuprorelin Market 2021-2025

US$ 2,600.00

Leuprolide is a synthetic gonadotropin drug used to treat hormone-responsive cancers such as prostate cancer and breast cancer. It can also be used to treat precocious puberty and prevent premature ov...

June 2021 50 pages

Investigation Report on China's Levofloxacin Market 2021-2025

US$ 2,600.00

Levofloxacin, developed by Daiichi Sankyo, is used to treat bacterial infectious diseases such as community pneumonia, sinusitis, urinary tract infections. Levofloxacin tablets were approved in China...

June 2021 50 pages

Filters

Clear all